Banner News

Taiwan, January 1, 2022 –It is with great pleasure that we announce the establishment of our Branch in the Republic of China, Taiwan. This important milestone comes as part of our continuous efforts to expand our reach and make our products and services as widely available as possible. Importantly, this initiative continues our focus, ADVANCED MEDTECH FOR ALL.

The choice of Taiwan is very clear.

“As a member of international organisations such as the World Trade Organisation (WTO) and the Asia Pacific Economic Cooperation (APEC), Taiwan is highly free in economic activities. Coupled with its economic stability and measures being taken to cut red tape and remove bureaucracy from business procedures, it was an easy decision”, said Dr. Winston Wong Jr., Chairman and CEO of Credo Diagnostics Biomedical.

“Besides, Taiwan has demonstrated that their diversified pool of biotech talents has high-quality standards. In addition to their outstanding medical system, Taiwan offers a comprehensive supply chain for the biomedical industry. Taking advantages of the many business friendly offerings in Taiwan, Credo Diagnostics aims to provide excellent and accurate medical solutions to improve the lives of people around the world.”


About Credo Diagnostics Biomedical Pte. Ltd.

Credo Diagnostics develops and manufactures innovative, easy-to-use and rapid molecular diagnostic solutions for Point-of-Care (POC) applications at affordable costs without compromising accuracy and speed in the areas Human Health. Leveraging solid and established science, combined with efficient integration and strategic innovation, Credo Diagnostics Biomedical provides advanced medical technologies for all.

Media Contact:
Cheryl Yang
Tel: +886 2-2697-3998 Ext.1116



We at Credo Diagnostics pioneer accessible diagnostic platforms to improve the lives of those we love. We believe providing the right information to the right people at the right time leads to better outcomes.